Schedule Your Heart Screening For Life Threatening Arrhythmias

New diagnostic technology can predict those at risk for life-threatening ventricular arrhythmias than can cause Sudden Cardiac Death (SCD). Manhattan Cardiology’s mission is to reduce the impact of Sudden Cardiac Syndrome by providing non-invasive technologies to identify individuals at risk of life-threatening arrhythmias. Our innovative diagnostic test is used to measure Microvolt T-Wave Alternans (MTWA), a subtle beat-to-beat fluctuation in the T-wave segment of the ECG. Schedule your screening today by clicking here.